Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Griebel

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 2004
Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716)Caroline Cohen, Ghislaine Perrault, Guy Griebel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 18, 2009
The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic miceDenis Boulay, Olivier Bergis, Patrick Avenet, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2004
Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415Jeanne Stemmelin, Ludovit Lukovic, Nicolas Salome, et al.
Behavioural Brain Research|December 3, 2014
The CRF₁ receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: comparison with paroxetine and d-cycloserineJulie Philbert, Sandra Beeské, Catherine Belzung, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 3, 2006
Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the ratCaroline Louis, Caroline Cohen, Ronan Depoortère, et al.
Current Protocols in Neuroscience|April 23, 2008
Defensive responses to predator threat in the rat and mouseD Caroline Blanchard, Robert J Blanchard, Guy Griebel
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 23, 2003
Impaired memory following predatory stress in mice is improved by fluoxetineWissam El Hage, Sylvie Peronny, Guy Griebel, et al.
Neuroscience and Biobehavioral Reviews|November 9, 2010
Risk assessment as an evolved threat detection and analysis processD Caroline Blanchard, Guy Griebel, Roger Pobbe, et al.
Current Pharmaceutical Design|May 17, 2005
Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disordersGuy Griebel, Jeanne Stemmelin, Claudine Serradeil-Le Gal, et al.
Behavioural Brain Research|September 12, 2009
Implication of beta3-adrenoceptors in the antidepressant-like effects of amibegron using Adrb3 knockout mice in the chronic mild stressJeanne Stemmelin, Caroline Cohen, Ipek Yalcin, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 2004
Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716)Caroline Cohen, Ghislaine Perrault, Guy Griebel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 18, 2009
The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic miceDenis Boulay, Olivier Bergis, Patrick Avenet, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2004
Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415Jeanne Stemmelin, Ludovit Lukovic, Nicolas Salome, et al.
Behavioural Brain Research|December 3, 2014
The CRF₁ receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: comparison with paroxetine and d-cycloserineJulie Philbert, Sandra Beeské, Catherine Belzung, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 3, 2006
Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the ratCaroline Louis, Caroline Cohen, Ronan Depoortère, et al.
Current Protocols in Neuroscience|April 23, 2008
Defensive responses to predator threat in the rat and mouseD Caroline Blanchard, Robert J Blanchard, Guy Griebel
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 23, 2003
Impaired memory following predatory stress in mice is improved by fluoxetineWissam El Hage, Sylvie Peronny, Guy Griebel, et al.
Neuroscience and Biobehavioral Reviews|November 9, 2010
Risk assessment as an evolved threat detection and analysis processD Caroline Blanchard, Guy Griebel, Roger Pobbe, et al.
Current Pharmaceutical Design|May 17, 2005
Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disordersGuy Griebel, Jeanne Stemmelin, Claudine Serradeil-Le Gal, et al.
Behavioural Brain Research|September 12, 2009
Implication of beta3-adrenoceptors in the antidepressant-like effects of amibegron using Adrb3 knockout mice in the chronic mild stressJeanne Stemmelin, Caroline Cohen, Ipek Yalcin, et al.
Pageof 7